P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 901–1,000 of 1,000
Basic research on quercetin in liver cancer: Progress and perspectives
Liu, B., Yu, Y., Wang, R., Wu, Y., & Sun, K. (2025) · Medicine · doi:10.1097/md.0000000000045534 · Cited by 1
“[87] Guan et al [42] proposed that quercetin competes with p53 for the binding site of Yin Yang 1 (YY1) by binding to the multifunctional transcription factor YY1 protein, thereby disrupting the interaction of YY1-p53 and promoting the activation of p53.”
p53 and fatty acids collaborate to trigger ferroptosis via the FBXO2-FABP5 axis in colorectal cancer
Tong, J., Han, T., Deng, J., Gan, Y., Ruan, R., Zhao, W., Xiong, C., Liao, Q., Chen, S., Bu, H., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104043 · Cited by 3
“This could be achieved through the upregulation of various target genes that improve the viability of cancer cells, induce drug resistance, or provide feedback inhibition of p53, thereby sustaining their own survival and proliferation [30,48 – 51].”
Modulating p53 condensation rewires transcriptional programs to enhance tumor suppression
Liu, Y., Jia, H., Guan, X., Guo, J., Wang, J., Xiang, S., Chen, J., Liu, Y., Li, Y., & Wang, G. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.023 · Cited by 2
Lu, X., Zang, K., Diao, C., Dong, C., & Ren, J. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c08142 · Cited by 1
PIP4K2A/2B inhibitor suppresses tumor growth in a xenograft model of NSCLC
He, Z., Chen, S., Bosenberg, M., Muthusamy, V., Xi, Y., Wang, H., Micheli, F., Cianciulli, A., Beato, C., Zandt, M. V., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115952 · Cited by 1
“11,19,25,54 These mechanistic delineations provided a conceptual foundation for targeting PIP4K in cancer: as has been demonstrated for genetically manipulated MEFs and multiple sarcoma and breast cancer cell lines, the metabolic vulnerability induced by PIP4K inactivation could be exploited to…”
Arias, N., Rodríguez‐Fernández, L., Zorzo, C., Pena-León, V., Cordero, L. M., Gutiérrez‐Menéndez, A., Martínez, & Arias, J. D. (2026) · GeroScience · doi:10.1007/s11357-026-02278-9 · Cited by 1
“BCL-2 family proteins and the tumor suppressor protein p53 are key regulators of apoptosis signaling pathways [88, 89]. p53 modulates the activity of the BCL-2 family through both transcription-dependent and transcription-independent mechanisms [90, 91].”
Citrate-derived acetyl-CoA partitioning as a metabolic-epigenetic checkpoint in cancer
Komninou, D., & Papanikolaou, N. A. (2026) · Metabolism Open · doi:10.1016/j.metop.2026.100496 · Cited by 1
Alive failures behind the windows of cancer therapy
Islam, M. T. (2017) · International Journal of Medicine · doi:10.14419/ijm.v5i2.7035 · Cited by 1
Jiang, S., & Xie, Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_14 · Cited by 1
The Role of Sestrins in the Regulation of the Cellular Response to Stress
Budanov, A. V. (2022) · Biology Bulletin Reviews · doi:10.1134/s2079086422040028 · Cited by 2
“One of the key regulators of the SESN1 gene is the p53 protein, which is activated by various types of stress, including DNA damage in response to radiation and ultraviolet (UV) irradiation and treatment with chemotherapeutic drugs, as well as in response to oxidative stress, disturbances in the cytoskeleton assembly,…”
BackgroundInfluentialCandesartan Cilexetil Decreases Genes Expression of p53 and TNF-α in Mice Serum
Maleek, M. I. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s03.193 · Cited by 1
Ma, D., Liu, S., He, Q., Kong, L., Liu, K., Xiao, L., Xin, Q., Bi, Y., Wu, J., & Jiang, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-36650-y · Cited by 4
Suárez, M. F., Itakura, T., Pany, S., Jeong, S., Chintala, S. K., Raizman, M. B., Riesinger, S. W., Lazarova, T. I., Echenique, J., Serra, H. M., et al. (2023) · Stresses · doi:10.3390/stresses3030044 · Cited by 1
“This is consistent with the known mechanism of TP53 pathway activation; TP53 protein is stabilized in response to cellular stress [45].”
BackgroundResultInfluentialDamdinbazar, D., Bolortuya, B., Oyunbat, N., Ariya, E., Namuun, L., Tuvshinjargal, K., Binderiya, B., Bold, N., Davaakhuu, G., & Oyunsuren, T. (2023) · Proceedings of the Institute of Biology · doi:10.5564/pib.v39i1.3143 · Cited by 1
“Харин p53 уургийн өөрийн үйл ажиллагаа нь 50 гаруй ТДӨ-өөр зохицуулагддаг [58].”
BackgroundIn addition to early biomarkers, what else can be done with urine?
Chen, Y. E., & Gao, Y. (2024) · URINE · doi:10.1016/j.urine.2023.12.001 · Cited by 1
Autophagy and Reactive Oxygen Species in Cancer: An Introduction
Kumar, P., Ruchitha, C., Gowtham, A., & Kaundal, R. K. (2024) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-66421-2_1 · Cited by 1
Sivagurunathan, N., & Latchoumycandane, C. (2025) · Gene Expression · doi:10.14218/ge.2025.00001 · Cited by 3
Zhu, L., Xu, Y., Chen, X., Qin, J., Niu, T., Zhu, Y., Jiang, Y., Zhao, S., Liu, K., Lü, J., et al. (2020) · BioMed Research International · doi:10.1155/2020/4534289 · Cited by 4
“As a tumor suppressor, p53 can repair cells damage and clear cells that cannot be repaired [8].”
Health and Fitness at the Single-Cell Level
Green, D. R. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0418 · Cited by 1
“As a result, p53 induces a variety of responses, including homeostatic repair responses and apoptosis (22).”
BackgroundAssociation of the TP53 Codon 72 Polymorphisms with PCOS Female Infertility in Karbala City
Radhi, I. J., Alkhaleeli, A. B. M., & Abdulwahid, H. H. (2021) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v15i4.16895 · Cited by 1
“These studies agree with our results but we still need extra studies and research in this field, because there are no local or even regional studies [13].”
ResultFerroptosis: Can Iron Be the Downfall of a Cell?
Fırat, A. A. (2021) · Biochemistry · doi:10.5772/intechopen.101426 · Cited by 1
Anticancer Properties of Some Antioxidants
Ünsal, V. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-9258-8.ch018 · Cited by 1
McDade, S. S., & Fischer, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64985-1 · Cited by 1
Biomimetic Synthesis of Rhytidenone A and Mode of Action of Cytotoxic Rhytidenone F
Yue, Z., Lam, H. C., Chen, K., Siridechakorn, I., Liu, Y., Pudhom, K., & Lei, X. (2019) · Angewandte Chemie · doi:10.1002/ange.201914257 · Cited by 1
Palminha, N. M., Hashish, S. A., Rabie, E., & Saber, S. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-9205-5_4 · Cited by 1
Methylglyoxal induces nuclear accumulation of p53 and γH2AX in normal and cancer cellsPreprint
Veß, A., & Hollemann, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.19.998773 · Cited by 1
tiantian, Q., Li, D., Yu, L., LiFang, G., Chao, W., Ren, H., & Yang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-154528/v1 · Cited by 1
“Its primary role is to inhibit tumorigenesis by controlling cell cycle progression, senescence, DNA repair, cell death and metabolism[18].”
BackgroundAgamia, N., Mulla, K. F. E., El‐Sayed, N., Ghazala, R. A., Maksoud, R. A. E., Elmonem, E. A., Talat, E., Zaki, I. A., Sabah, R. M., & Melnik, B. C. (2022) · Research Square · doi:10.21203/rs.3.rs-1609874/v1 · Cited by 2
Odell, A. F., Mannion, A. J., Jones, P. F., & Cook, G. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.04.498680 · Cited by 1
“hub for regulating the responses to diverse types of cellular stress, including DNA damage, hypoxia, oxidative damage and various metabolic demands (2, 3).”
BackgroundRadiation therapy: An old dog learning new tricks
Sato, A., Kraynak, J., Marciscano, A. E. E., & Galluzzi, L. (2022) · Methods in cell biology · doi:10.1016/s0091-679x(22)00139-x · Cited by 1
Abnormal homeostasis of P53 gene knockout mice can be reflected in urinary proteomePreprint
Pan, X., Yang, M., Bao, Y., Liu, Y., & Gao, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.29.538827 · Cited by 1
“The gene plays an irreplaceable role in cell cycle, autophagy, apoptosis, redox homeostasis, aging, metabolism, and other aspects, as shown in Figure 1 [4].”
BackgroundNatural Product Screen Identifies Asiatic Acid Targeting Mutant p53Preprint
Swargiary, G., Jamal, Q. M. S., Ojha, S. K., Jha, N. K., Singh, K. K., & Mani, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.23.550189 · Cited by 1
“Interestingly, there is mounting evidence indicating that p53 is a vital performer in controlling cellular energy metabolism too (Kruiswijk et al., 2015; Berkers et al., 2013; Matoba et al., 2006).”
BackgroundParallel networks that govern the transcriptional response to stress
Durham, S. A. (2022) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/9v8x-vd6d · Cited by 1
Okada, N. (2026) · Research Square · doi:10.21203/rs.3.rs-8535943/v1 · Cited by 1
Non-hydrolyzable acetyllysine analogs to study protein acetylation in vitro and in cells
Kienle, S. M., Sigg, M., Schneider, T., Stuber, K., Lehmann, J., Jansen, J., Stengel, F., Marx, A., Kovermann, M., & Scheffner, M. (2026) · Nature Communications · doi:10.1038/s41467-026-69782-6
“24 – 27).”
Thorne, L. S. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Consequences of IRF2BP2 Loss of Function in Mouse Development and Skeletal Muscle Regeneration
Ho, T. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5781
“inhibitor that halts the cell cycle in the G1 phase (43).”
BackgroundComputational biology approaches in drug repruposing and gene essentiality screening
Philips, S. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c2j30f
“malignancies – AKT1[162-164, 166, 171-175], TP53[167, 176, 177], CDH1[178, 179],”
BackgroundInfluentialAn investigation of the role of TRIB2 in steady state and stressed haematopoiesis
Liang, K. L. (2016) · Arrow@dit (Dublin Institute of Technology)
Doak, A. E. (2016) · CU Scholar (University of Colorado Boulder)
戸口, 侑., Kamada, R., Kanno, M., Imagawa, T., & Sakaguchi, K. (2017) · Chemistry Letters · doi:10.1246/cl.170980
Molecular Classification of Hepatocellular Carcinoma and Precision Medicine
Feely, M. (2017) · Molecular pathology library · doi:10.1007/978-3-319-68082-8_3
Intercellular Signaling Network Underlies Biological Time Across Multiple Temporal ScalesPreprint
Millstein, J., Summa, K. C., Yang, X., Zhu, J., Mi, H., Vitaterna, M. H., Turek, F. W., & Zhang, B. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/315788
Transcriptional Activity of TP53 and MDM2 in Chronically Exposed People at Later Time Points
Сергеевич, Н. В., & Аклеев, А. В. (2018) · Medical Radiology and radiation safety · doi:10.12737/article_5b83b6185814e7.31842273
Smarra, L. F. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2018.tde-20082018-170457
Report of the Signal Transduction Society Meeting 2018—Signaling: From Past to Future
Schirmer, B., Giehl, K., & Kubatzky, K. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010227
“Importantly, her basic research on p53 and its targets has led to the development of novel therapeutic approaches targeting cancer [32,33].”
BackgroundEixo XPC-P53-H202 e disfunção mitocondrial: qual é o fator central?
Freire, T. D. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2018.tde-12122018-114933
Hossain, K. (2018) · TSpace (University of Toronto) · Cited by 1
Nagam, S. L. S. S., & Jinka, R. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100684
Danao, K. R., Kohadkar, P. B., Mahapatra, D. K., & Mahajan, U. (2020) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2020.122319
Cuello, C., Martinez-Serrano, C. A., Cambra, J. M., Parrilla, I., Rodríguez‐Martínez, H., Gil, M. A., & Martinez, E. A. (2020) · doi:10.21203/rs.3.rs-35496/v1
Weng, H., Deng, T., Yuan, S., Huang, Q., Zeng, X., & Wang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-231421/v1
“In contrast, it promotes ferroptosis under high oxidative pressure [25].”
BackgroundTshifhiwa, N. (2021) · doi:10.32388/3np14m
“The transcription factor recognizes specific responsive DNA elements and regulates the transcription of genes involved in cellular metabolism, survival, senescence, apoptosis and the DNA damage response (Vousden and Prives, 2009, Kruiswijk et al., 2015).”
Backgroundde Santis, J. O. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2021.tde-04082021-125326 · Cited by 2
Cypermethrin-induced liver toxicity in Balb/c mice
Mahna, D., Puri, S., & Sharma, S. (2021) · Journal of Punjab Academy of Forensic Medicine & Toxicology · doi:10.5958/0974-083x.2021.00013.3
Redox regulation of the tumor suppressor p53
Shi, T. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/966 · Cited by 1
TRAIL-R Deficient Mice Are Protected From Neurotoxic Effects of Amyloid-βPreprint
Benedetto, G. D., Burgaletto, C., Serapide, M. F., Munafò, A., Bellanca, C. M., Mauro, R. D., Bernardini, R., & Cantarella, G. (2021) · Research Square · doi:10.21203/rs.3.rs-1124682/v1
Effect of Linc-00475 Regulation of p53 on Glycolysis and Survival in Gastric CancerPreprint
Zhang, C., Zhao, S., & Wang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-1136189/v1
The tumour suppressor p53 as a supporter of DNA replication
Klusmann, I. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7143
One-carbon metabolism in lung cancer
Yao, S. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8273
Zhang, H., Liu, Y., Wang, B., & Wang, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1473582/v2
Zhang, H., Liu, Y., Wang, B., & Wang, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1473582/v1
Bang, S., Bhatt, H. C., Chen, Y. Y., & Kurokawa, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101574
Faculty Opinions recommendation of Revisiting the hallmarks of cancer.
Vecchio, G., & Melillo, R. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727685941.793556548
Wang, M., Yang, J., Yang, L., & Wang, C. (2019) · doi:10.21203/rs.2.17133/v1
Bang, S., Bhatt, H. C., Chen, Y. Y., & Kurokawa, M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101574-1
(2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813635-5.16001-x
Mercurio, A. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732521613.793545511
Melatonin can enhancement p53 concentration and decrease micronucleus production rate in albino mice
Hameed, M. M., & Maleek, M. I. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.12108
“P53 is a transcription factor that binds DNA and functions physiologically as a homotetramer (Kruiswijk et al., 2015).”
BackgroundZhang, P., Brown, K., Barnes, D., Kitchen-Smith, I., Sims, D., Flanagan, A. M., Noon, S. D., Loo, P. V., Hargreaves, S., Cross, W., et al. (2022) · medRxiv · doi:10.1101/2022.09.28.22280453
“However, p53 also has pro124 survival target genes, like KITLG, and recent data from mouse models and human cancer cells suggest 125 that cancers retaining wild type p53 benefit from the activation of these genes [16, 17].”
BackgroundRadiation therapy: An old dog learning new tricks
Sato, A., Kraynak, J., Marciscano, A. E. E., & Galluzzi, L. (2023) · Methods in cell biology · doi:10.1016/s0091-679x(23)00036-5
Insulin-dependent GLUT4 is a risk factor for cancer in the prostatePreprint
González‐Menéndez, P., Morán-Álvarez, A., Mayo, J. C., Cernuda‐Cernuda, R., Álvarez-Artime, A., Hevia, D., Rodríguez‐González, P., Alonso, J. I. G., Lambert, C., Delgado, E., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2619954/v1
Macha, S. J., Koneru, B., Burrow, T. A., Zhu, C., Savitski, D., Rahman, R. L., Ronaghan, C. A., Nance, J., McCoy, K., Eslinger, C. R., et al. (2023) · doi:10.1158/0008-5472.c.6514106.v1
Analysis of Expression of RNA Helicases and Cofactors in Human Tissues and Cancer
Rathje, K. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9872
Yang, S., Huang, M., Dong, J., Song, L., & Wang, D. (2023) · Food Frontiers · doi:10.1002/fft2.262
Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors
An, Z., Bo, W., Jibao, Q., Jiang, L., & Jiang, J. (2023) · Iranian Journal of Public Health · doi:10.18502/ijph.v52i6.12957
Wu, D., Feng, B., Su, W. C., Xiong, W., Xu, M., Xu, A., Fu, B., & Li, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3165133/v1
RetractedRadiation Therapy in Patients with Germline Mutations: a Review of the Current Evidence
DeFoe, S. G., Balogun, Z., Sabih, Q., Lupinacci, K. M., & Barry, P. N. (2023) · Current Breast Cancer Reports · doi:10.1007/s12609-023-00502-5
Phoyen, S., Boonla, C., & Jindatip, D. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.241
Radiation therapy: An old dog learning new tricks
Sato, A., Kraynak, J., Marciscano, A. E. E., & Galluzzi, L. (2023) · Methods in cell biology · doi:10.1016/s0091-679x(23)00166-8
Jiang, S., & Xie, Y. (2023) · Springer eBooks · doi:10.1007/978-3-031-39171-2_7
Germ cell tumor treatment resistance and liquid biopsy-based microRNA biomarkers
Timmerman, D. M. (2024) · Utrecht University Repository (Utrecht University) · doi:10.33540/2055
Zhang, C., Li, X., Chen, X., Liu, W., Zhao, X., & Wang, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3978496/v1
Cui, X., Liu, C. X., Dong, P., Liu, C., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22799995
Cui, X., Liu, C. X., Dong, P., Liu, C., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22799998
Cui, X., Liu, C. X., Dong, P., Liu, C., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22800007
Bi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14670329
Cui, X., Liu, C. X., Dong, P., Liu, C., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22800004
Bi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14670332
Bi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14670323
Bi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14670362
Bi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14670326
Bi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14670335
Cui, X., Liu, C. X., Dong, P., Liu, C., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22800001
Targeting iron metabolism in cancer to induce ferroptosis: a type of programmed cell death
Beadman, R. (2024) · Cronfa (Swansea University) · doi:10.23889/suthesis.66249
Hdm2 disrupts HdmX-mediated nuclear export of p53 by sequestering it in nucleus
Ni, Y., Chen, H., Cheng, X., Sun, B., Wu, Z., Zhan, Q., & Zhuang, Z. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114185
Kim, S. H., & Oh, S. (2025) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-025-00182-1
“However, the p53 protein is stabilized in response to various intracellular and extra-cellular stresses, such as oxidative stress and DNA damage [36].”
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.